Impaired P2X1 receptor-mediated adhesion in eosinophils from asthmatic patients

Impaired P2X1 receptor-mediated adhesion in eosinophils from asthmatic patients

Eosinophils play an important role in the pathogenesis of asthma and can be activated by extracellular nucleotides released following cell damage or inflammation. For example, increased ATP concentrations were reported in bronchoalveolar lavage fluids of asthmatic patients. Although eosinophils are...

Podrobná bibliografie
Hlavní autoři:	Wright, A, Mahaut-Smith, M, Symon, F, Sylvius, N, Ran, S, Bafadhel, M, Muessel, M, Bradding, P, Wardlaw, A, Vial, C
Médium:	Journal article
Jazyk:	English
Vydáno:	American Association of Immunologists 2016

Podobné jednotky

Comparison of airway immunopathology of eosinophilic bronchitis and asthma.
Autor: Brightling, C, a další
Vydáno: (2003)

TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis.
Autor: Brightling, C, a další
Vydáno: (2002)

Mepolizumab in refractory eosinophilic asthma.
Autor: Pavord, I, a další
Vydáno: (2010)

IL-13 expression by blood T cells and not eosinophils is increased in asthma compared to non-asthmatic eosinophilic bronchitis
Autor: Mistry Vijay, a další
Vydáno: (2009-07-01)

Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma
Autor: Shrimanker, R, a další
Vydáno: (2017)

Eotaxin and the attraction of eosinophils to the asthmatic lung
Autor: Williams Timothy J, a další
Vydáno: (2001-03-01)

Characterisation of exacerbations of severe eosinophilic asthma (SEA) on mepolizumab compared to placebo
Autor: Shrimanker, R, a další
Vydáno: (2017)

Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma.
Autor: Berry, M, a další
Vydáno: (2007)

COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils
Autor: Eltboli, O, a další
Vydáno: (2014)

Eosinophil Progenitors in Patients With Non-Asthmatic Eosinophilic Bronchitis, Eosinophilic Asthma, and Normal Controls
Autor: Chen Zhan, a další
Vydáno: (2022-03-01)

Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients
Autor: Ilknur Basyigit, a další
Vydáno: (2004-01-01)

IL-4-expressing bronchoalveolar T cells from asthmatic and healthy subjects preferentially express CCR 3 and CCR 4.
Autor: Morgan, A, a další
Vydáno: (2005)

Comparison of the peripheral blood eosinophil count using near-patient testing and standard automated laboratory measurement in healthy, asthmatic and COPD subjects
Autor: Hambleton, K, a další
Vydáno: (2017)

Evaluation Role of IL-13 and Eosinophils in Adult Asthmatic Patients
Autor: Meraim A. Kazaal, a další
Vydáno: (2023-06-01)

Mepolizumab and exacerbations of refractory eosinophilic asthma.
Autor: Haldar, P, a další
Vydáno: (2009)

Asthma: Eosinophil Disease, Mast Cell Disease, or Both?
Autor: Bradding Peter
Vydáno: (2008-06-01)

Serum cytokines and treatment response in atopic and non-atopic eosinophilic asthmatics
Autor: Jamille Fernandes, a další
Vydáno: (2020-08-01)

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
Autor: Green, R, a další
Vydáno: (2002)

Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis.
Autor: Berry, M, a další
Vydáno: (2004)

Vascular remodeling is a feature of asthma and nonasthmatic eosinophilic bronchitis.
Autor: Siddiqui, S, a další
Vydáno: (2007)

Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis
Autor: Haldar, P, a další
Vydáno: (2014)

The release of eosinophil chemotactic activity and eosinophil chemokinesis inhibitory activity by mononuclear cells from atopic asthmatic and non-atopic subjects
Autor: J. Grzegorczyk, a další
Vydáno: (2000-01-01)

Objective quantitative analysis of eosinophils and bronchial epithelial cells in induced sputum by laser scanning cytometry.
Autor: Woltmann, G, a další
Vydáno: (1999)

Eosinophils in COPD: just another biomarker?
Autor: Bafadhel, M, a další
Vydáno: (2017)

Investigating blood eosinophil count thresholds in patients with COPD
Autor: Russell, R, a další
Vydáno: (2018)

Interleukin-4 and -13 expression is co-localized to mast cells within the airway smooth muscle in asthma.
Autor: Brightling, C, a další
Vydáno: (2003)

Mast-cell infiltration of airway smooth muscle in asthma.
Autor: Brightling, C, a další
Vydáno: (2002)

Characterising non-eosinophilic COPD
Autor: Hambleton, K, a další
Vydáno: (2015)

Identifying clinical and demographic characteristic differences between eosinophilic and non-eosinophilic asthma and detecting predictors of eosinophilic asthma among Egyptian asthmatic patients
Autor: Maged Mohamed Refaat, a další
Vydáno: (2022-10-01)

The role of oral methotrexate as a steroid sparing agent in refractory eosinophilic asthma.
Autor: Bilocca, D, a další
Vydáno: (2017)

Is it possible to claim or refute sputum eosinophils ≥ 3% in asthmatics with sufficient accuracy using biomarkers?
Autor: Sophie F. Demarche, a další
Vydáno: (2017-07-01)

Recombinant surfactant protein-D selectively increases apoptosis in eosinophils of allergic asthmatics and enhances uptake of apoptotic eosinophils by macrophages.
Autor: Mahajan, L, a další
Vydáno: (2008)

Role of Adhesion Molecules in Eosinophil Activation: A Comparative Study on the Effect of Adhesion Molecules on Eosinophil Survival
Autor: Kazutoshi Yamaguchi, a další
Vydáno: (2004-01-01)

Eosinophil migration is enhanced towards IL-5 and eotaxin in COPD
Autor: Lababidi, R, a další
Vydáno: (2017)

Association between protein intake, serum albumin and blood eosinophil in US asthmatic adults
Autor: Jun Wen, a další
Vydáno: (2024-05-01)

Do blood eosinophils strictly reflect airway inflammation in COPD? Comparison with asthmatic patients
Autor: Patrizia Pignatti, a další
Vydáno: (2019-07-01)

Relationship between triglyceride-glucose index and blood eosinophils among asthmatic individuals in the USA
Autor: Jun Wen, a další
Vydáno: (2024-05-01)

Fevipiprant reduces airway smooth muscle mass in asthmatics via PGD2 receptor antagonism
Autor: Saunders, R, a další
Vydáno: (2017)

Fevipiprant reduced airway smooth muscle massin asthmatics via PGD2Receptor antagonism
Autor: Saunders, R, a další
Vydáno: (2017)

The significance of eosinophilic airway inflammation in asthma
Autor: Pavord, I, a další
Vydáno: (2002)